- •We report on 4439 ovarian cancer cases undergoing multi-gene cancer panel testing.
- •Genes with positive results, in order of frequency, included: BRCA1, BRCA2, CHEK2, BRIP1, ATM, RAD51C, RAD51D, and MSH6.
- •Homologous recombination genes account for 33.7% of findings.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- SEER statistics 2015.http://seer.cancer.gov/csr/1975_2012/(accessed February 25, 2016)Date: 1975–2012
- BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2012; 30: 2654-2663https://doi.org/10.1200/JCO.2011.39.8545
- Hereditary ovarian cancer: beyond the usual suspects.Gynecol. Oncol. 2012; 124: 347-353https://doi.org/10.1016/j.ygyno.2011.12.415
- The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.Gynecol. Oncol. 2006; 101: 238-243https://doi.org/10.1016/j.ygyno.2005.10.029
- International Agency for Research on Cancer World Health Organization WHO Classification of Tumours of Female Reproductive Organs. 4th ed. International Agency for Research on Cancer, Lyon2014
- Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype.Adv. Anat. Pathol. 2013; 20: 378-386https://doi.org/10.1097/PAP.0b013e3182a92cf8
- Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors.Gynecol. Oncol. 2011; 121: 462-465https://doi.org/10.1016/j.ygyno.2011.02.010
- Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.Cancer Res. 2011; 71: 2222-2229https://doi.org/10.1158/0008-5472.CAN-10-3958
- Germline mutations in RAD51D confer susceptibility to ovarian cancer.Nat. Genet. 2011; 43: 879-882https://doi.org/10.1038/ng.893
- Germline RAD51C mutations confer susceptibility to ovarian cancer.Nat. Genet. 2012; 44 (author reply 476): 475-476
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.Nat. Genet. 2010; 42: 410-414https://doi.org/10.1038/ng.569
- Mutations in BRIP1 confer high risk of ovarian cancer.Nat. Genet. 2011; 43: 1104-1107https://doi.org/10.1038/ng.955
- Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer.J. Natl. Cancer Inst. 2015; 107https://doi.org/10.1093/jnci/djv214
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.Proc. Natl. Acad. Sci. U. S. A. 2011; 108: 18032-18037https://doi.org/10.1073/pnas.1115052108
- Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.Gynecol. Oncol. 2017; 147: 375-380https://doi.org/10.1016/j.ygyno.2017.08.030
- SGO.(accessed February 25, 2016)
- (accessed February 25, 2016)
- Multi-disciplinary summit on genetics services for women with gynecologic cancers: a Society of Gynecologic Oncology White Paper.Gynecol. Oncol. 2017; https://doi.org/10.1016/j.ygyno.2017.06.002
- SGO.https://www.sgo.org/clinical-practice/guidelines/next-generation-cancer-gene-panels-versus-gene-by-gene-testing/(accessed February 25, 2016)Date: 2014
- The human genome browser at UCSC.Genome Res. 2002; 12 (Article published online before print in May 2002): 996-1006https://doi.org/10.1101/gr.229102
- Fast and accurate short read alignment with Burrows–Wheeler transform.Bioinformatics. 2009; 25: 1754-1760https://doi.org/10.1093/bioinformatics/btp324
- From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline.Curr. Protoc. Bioinformatics. 2013; 43: 11.10.1-33https://doi.org/10.1002/0471250953.bi1110s43
- The sequence alignment/map format and SAMtools.Bioinforma. Oxf. Engl. 2009; 25: 2078-2079https://doi.org/10.1093/bioinformatics/btp352
- ACMG recommendations for standards for interpretation and reporting of sequence variations: revisions 2007.Genet. Med. Off. J. Am. Coll. Med. Genet. 2008; 10: 294-300https://doi.org/10.1097/GIM.0b013e31816b5cae
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.Genet Med Off J Am Coll Med Genet. 2015; 17: 405-424https://doi.org/10.1038/gim.2015.30
R Proj Stat Comput n.d. https://www.r-project.org/ (accessed January 11, 2017).
- Inherited mutations in women with ovarian carcinoma.JAMA Oncol. 2015; : 1-9https://doi.org/10.1001/jamaoncol.2015.5495
- BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.Cancer. 2005; 104: 2807-2816https://doi.org/10.1002/cncr.21536
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.Gynecol. Oncol. 2011; 121: 353-357https://doi.org/10.1016/j.ygyno.2011.01.020
- Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.Nat. Genet. 2002; 31: 55-59https://doi.org/10.1038/ng879
- ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.Am. J. Hum. Genet. 2000; 66: 494-500
- Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population.J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2015; 33: 2901-2907https://doi.org/10.1200/JCO.2015.61.2408
- Frequency of germline PALB2 mutations among women with epithelial ovarian cancer.Familial Cancer. 2017; 16: 29-34https://doi.org/10.1007/s10689-016-9919-z
- Genetic characterization of early onset ovarian carcinoma.Gynecol. Oncol. 2016; 140: 221-225https://doi.org/10.1016/j.ygyno.2015.12.017
- Prat. Tumors of the ovary and peritoneum.in: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press, Lyon, France2003
- The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.Hum. Mol. Genet. 2014; 23: 4703-4709https://doi.org/10.1093/hmg/ddu172
- Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer.Gynecol. Oncol. 2017; https://doi.org/10.1016/j.ygyno.2017.01.005
- The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.Am. J. Hum. Genet. 1999; 65: 1725-1732https://doi.org/10.1086/302671
- Cancer genetic counseling and testing in an era of rapid change.J. Genet. Couns. 2017; 26: 1244-1253https://doi.org/10.1007/s10897-017-0099-2